170 related articles for article (PubMed ID: 26512967)
21. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
[TBL] [Abstract][Full Text] [Related]
22. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center's results].
Parovichnikova EN; Troitskaia VV; Kliasova GA; Kuz'mina LA; Sokolov AN; Paramonova EV; Galstian GM; Kessel'man SA; Drokov MIu; Vasil'eva VA; Obukhova TN; Kulikov SM; Savchenko VG
Ter Arkh; 2014; 86(7):14-23. PubMed ID: 25314773
[TBL] [Abstract][Full Text] [Related]
23. Analysis of MDR1 and MDR3 multidrug resistance gene expression and amplification in consecutive samples in patients with acute leukaemias.
MacFarland A; Dawson AA; Pearson CK
Leuk Lymphoma; 1995 Sep; 19(1-2):135-40. PubMed ID: 8574159
[TBL] [Abstract][Full Text] [Related]
24. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
[TBL] [Abstract][Full Text] [Related]
25. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration.
Chapuy B; Koch R; Radunski U; Corsham S; Cheong N; Inagaki N; Ban N; Wenzel D; Reinhardt D; Zapf A; Schweyer S; Kosari F; Klapper W; Truemper L; Wulf GG
Leukemia; 2008 Aug; 22(8):1576-86. PubMed ID: 18463677
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.
Liu Y; Peng H; Zhang JT
Mol Pharmacol; 2005 Aug; 68(2):430-8. PubMed ID: 15901850
[TBL] [Abstract][Full Text] [Related]
27. Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?
Steinbach D; Friedrich J; Dawczynski K; Furchtbar S; Gruhn B; Wittig S; Zintl F; Sauerbrey A
Leuk Lymphoma; 2005 Sep; 46(9):1357-63. PubMed ID: 16109615
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of ABC transporter expression in canine multicentric lymphoma.
Zandvliet M; Teske E; Schrickx JA; Mol JA
Vet J; 2015 Aug; 205(2):263-71. PubMed ID: 25475167
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
Damiani D; Tiribelli M; Michelutti A; Geromin A; Cavallin M; Fabbro D; Pianta A; Malagola M; Damante G; Russo D; Fanin R
Leuk Res; 2010 Jul; 34(7):942-5. PubMed ID: 20122734
[TBL] [Abstract][Full Text] [Related]
31. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.
Marzac C; Garrido E; Tang R; Fava F; Hirsch P; De Benedictis C; Corre E; Lapusan S; Lallemand JY; Marie JP; Jacquet E; Legrand O
Haematologica; 2011 Sep; 96(9):1293-301. PubMed ID: 21606172
[TBL] [Abstract][Full Text] [Related]
32. Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
Tiribelli M; Geromin A; Michelutti A; Cavallin M; Pianta A; Fabbro D; Russo D; Damante G; Fanin R; Damiani D
Cancer; 2011 May; 117(10):2156-62. PubMed ID: 21523728
[TBL] [Abstract][Full Text] [Related]
33. [Expression of ATP-binding cassette transporter genes in nasopharyngeal carcinoma].
DU SS; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):449-52. PubMed ID: 18359711
[TBL] [Abstract][Full Text] [Related]
34. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.
Kaspers GJ; Zimmermann M; Reinhardt D; Gibson BE; Tamminga RY; Aleinikova O; Armendariz H; Dworzak M; Ha SY; Hasle H; Hovi L; Maschan A; Bertrand Y; Leverger GG; Razzouk BI; Rizzari C; Smisek P; Smith O; Stark B; Creutzig U
J Clin Oncol; 2013 Feb; 31(5):599-607. PubMed ID: 23319696
[TBL] [Abstract][Full Text] [Related]
36. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
37. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.
Damiani D; Tiribelli M; Calistri E; Geromin A; Chiarvesio A; Michelutti A; Cavallin M; Fanin R
Haematologica; 2006 Jun; 91(6):825-8. PubMed ID: 16704962
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
40. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
